Basics Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system. IPO Date: November 19, 2015 Sector: Healthcare Industry: Biotech Market Cap: $5.3B Activated in VL: True Average Daily Range Avg Daily Range: $1.13 | 3.00% Avg Daily Range (30 D): $1.65 | 1.53% Avg Daily Range (90 D): $2.04 | 1.80% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .51M Avg Daily Volume (90 D): .69M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 39 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 3,220 Avg Inst. Trade: $2.86M Avg Inst. Trade (30 D): $5.83M Avg Inst. Trade (90 D): $5.85M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.54M Avg Closing Trade (30 D): $7.87M Avg Closing Trade (90 D): $8.68M Avg Closing Volume: 52.94K     News Jun 5, 2025 @ 7:19 AM 2 Soaring Stocks Wth More Upside Potential Source: Prosper Junior Bakiny Jun 4, 2025 @ 11:00 PM Investor Alert: Class Action Lawsuits Against Gene... Source: Johnson Fistel, Pllp May 29, 2025 @ 11:00 AM Axsome Therapeutics to Participate in Upcoming Inv... Source: N/A May 27, 2025 @ 7:44 PM Why Is Teva Stock Trading Higher On Tuesday? Source: Vandana Singh May 14, 2025 @ 11:30 PM Is Axsome Therapeutics Stock Worth the Risk? A Com... Source: The Motley Fool Financials   TTM Q1 2025 Q4 2024 Basic EPS $-5.77 $-1.22 $-1.54 Diluted EPS $-5.77 $-1.22 $-1.54 Revenue $ 432.16M $ 121.46M $ 118.77M Gross Profit $ $ $ Net Income / Loss $ -278.27M $ -59.41M $ -74.91M Operating Income / Loss $ -270.27M $ -56.98M $ -72.62M Cost of Revenue $ $ $ Net Cash Flow $ -30.53M $ -14.44M $ -11.99M PE Ratio